Comment on "Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients".
Go J YoshidaPublished in: Molecular diagnosis & therapy (2019)
Keyphrases
- end stage renal disease
- cell proliferation
- newly diagnosed
- chronic kidney disease
- ejection fraction
- low dose
- peritoneal dialysis
- epithelial mesenchymal transition
- prognostic factors
- skeletal muscle
- cardiovascular events
- stem cells
- type diabetes
- patient reported outcomes
- coronary artery disease
- mesenchymal stem cells
- signaling pathway
- atrial fibrillation
- drug delivery
- protein kinase